PALO ALTO, Calif., Oct. 24 /PRNewswire-FirstCall/ -- Jazz Pharmaceuticals, Inc. (Nasdaq: JAZZ) today announced that it will report its third quarter 2007 financial results on Tuesday, November 6, 2007, following the close of the U.S. financial markets. Jazz Pharmaceuticals will host an investor conference call and live audio webcast to discuss the quarterly results and company updates on November 6, 2007, at 5:00 p.m. Eastern Time/2:00 p.m. Pacific Time.
The live webcast and press release may be accessed on Jazz Pharmaceuticals' website at http://www.jazzpharmaceuticals.com. Please connect to the website prior to the start of the conference call to ensure adequate time for any software downloads that may be necessary to listen to the webcast. An archived version of the webcast will be available through November 20, 2007.
Investors may participate in the conference call by dialing 1-866-770-7120 in the U.S., or 1-617-213-8065 outside the U.S., and entering passcode 57344568. A replay of this call will be available until November 20, 2007 at 1-888-286-8010 (U.S.), or 1-617-801-6888 (international), using the passcode 41294935.
The webcast is also being distributed through the Thomson StreetEvents Network to both institutional and individual investors. Individual investors can listen to the call at http://www.fulldisclosure.com and institutional investors can access the call via http://www.streetevents.com.
About Jazz Pharmaceuticals, Inc.
Jazz Pharmaceuticals is a specialty pharmaceutical company focused on identifying, developing and commercializing innovative products to meet unmet medical needs in neurology and psychiatry. For further information, please visit http://www.JazzPharmaceuticals.com.
Jazz Pharmaceuticals, Inc.
Executive Director, Finance
Karen L. Bergman, 650-575-1509
Michelle Corral, 415-794-8662
|SOURCE Jazz Pharmaceuticals, Inc.|
Copyright©2007 PR Newswire.
All rights reserved